CRANBURY, N.J.--(BUSINESS WIRE)--Aug. 8, 2006--Kos Pharmaceuticals, Inc. (Nasdaq: KOSP - News): Kos Pharmaceuticals, Inc. (Nasdaq: KOSP - News) today announced financial results for the second quarter ended June 30, 2006. For the second quarter of 2006, revenue increased almost 25% to a record $223.7 million, up from $179.4 million for the second quarter of 2005. Revenue during the quarter was negatively impacted by approximately $4 million as a result of reductions in wholesaler inventories pursuant to inventory management agreements. As of the end of the quarter, inventories held by the company’s three largest wholesalers were at or below the levels provided for in the inventory management agreements.
